XML 29 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1

Segment Information

9 Months Ended

Sep. 30, 2018

Segment Information [Abstract]

Segment Information

14.  Segment Information

We have two reportable segments organized according to our products and services: Medical Devices and Preservation Services.  The Medical Devices segment includes external revenues from product sales of BioGlue; BioFoam® Surgical Matrix; JOTEC products, since the JOTEC Acquisition; On-X products; CardioGenesis cardiac laser therapy; PerClot; and PhotoFix.  The Preservation Services segment includes external services revenues from the preservation of cardiac and vascular tissues.  There are no intersegment revenues. 



The primary measure of segment performance, as viewed by our management, is segment gross margin, or net external revenues less cost of products and preservation services.  We do not segregate assets by segment; therefore, asset information is excluded from the segment disclosures below.



The following table summarizes revenues, cost of products and preservation services, and gross margins for our operating segments (in thousands): 




	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2018			2017			2018			2017
Revenues:
Medical devices	$	45,152		$	27,029		$	138,063		$	84,519
Preservation services		19,446			16,970			56,979			52,357
Total revenues		64,598			43,999			195,042			136,876

Cost of products and preservation services:
Medical devices		12,459			6,220			40,166			21,196
Preservation services		9,425			7,917			27,083			23,401
Total cost of products and preservation services		21,884			14,137			67,249			44,597

Gross margin:
Medical devices		32,693			20,809			97,897			63,323
Preservation services		10,021			9,053			29,896			28,956
Total gross margin	$	42,714		$	29,862		$	127,793		$	92,279



The following table summarizes net revenues by product and service (in thousands): 


















	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2018			2017			2018			2017
Products:
BioGlue and BioFoam	$	15,646		$	15,730		$	48,685		$	48,094
JOTEC		15,004			--			46,669			--
On-X		11,298			8,326			33,495			27,048
CardioGenesis cardiac laser therapy		1,590			1,489			4,514			5,130
PerClot		882			886			2,822			2,641
PhotoFix		732			598			1,878			1,606
Total products		45,152			27,029			138,063			84,519

Preservation services:
Cardiac tissue		9,502			7,932			26,660			23,911
Vascular tissue		9,944			9,038			30,319			28,446
Total preservation services		19,446			16,970			56,979			52,357

Total revenues	$	64,598		$	43,999		$	195,042		$	136,876





X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI http://asc.fasb.org/topic&trid=2134510

+ Details

Name:	us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration